As an Entrepreneur-in-Residence, Sacha will work with CDRD leadership to identify specific areas of strategic commercial opportunity, and then in partnership with other stakeholders, drive the building of a new company of scale that can develop those opportunities, and grow into a strong new anchor for Canada’s life science sector.
Sacha has been a life sciences investor, company innovator, and leader, and she has managed the entire commercialization cycle from spinning technology out of academia, raising venture capital financing, in-licensing assets into emerging companies, and partnering with global players. She has worked and invested across Canada and globally, most recently as CEO and Director of Biosys UK Ltd., a venture-backed, clinical stage microbiome company headquartered in London.
Sacha Mann was also previously an investor with Inventages Venture Capital, a respected global venture capital firm focused on life sciences, nutrition and wellness that raised €500M for their most recent fund. Prior to Inventages, she was an early-stage investor focused on innovation, company formation and investment in the UK (Archangels) and Canada (BDC Capital).
Sacha Mann holds a BSc in Chemistry (with Honours) from the University of British Columbia; an MSc from Johns Hopkins University (First Class Standing) in Biotechnology; and an MBA specializing in Technology (First Class Standing) from Simon Fraser University. She is a member of the Kauffman Fellows (Class 12), a global venture leadership organization with over 500 Fellows in over 40 countries.